Navigation Links
Frost & Sullivan: Shift from Analog Mammography Systems to Digital Mammography Systems Will Boost the European Mammography Systems Market
Date:5/6/2009

LONDON, May 6 /PRNewswire/ -- Analog screening systems are gradually being replaced by digital mammography systems. Screening programmes for breast cancer detection are responsible for driving the market. A majority of screening programmes have already been implemented in European countries. However, in some others, implementation of these programmes is proceeding slowly but steadily, leading to the increased installation of mammography systems.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

In the diagnostic market, the more advantageous and efficient prone biopsy units are showing more potential for growth, because of their enhanced ability to provide biopsy guidance. Moreover, prone biopsy units offer a cost advantage over add-on upright systems.

New analysis from Frost & Sullivan (http://www.medicalimaging.frost.com), European Mammography Systems Market, finds that the market earned revenues of $219.0 million in 2007 and estimates this to reach $346.0 million in 2014. This research examines the following market segments: full-field digital mammography (FFDM), analog mammography systems, diagnostic mammography systems and computed radiography.

If you are interested in a virtual brochure, which provides a brief synopsis of the research and a table of contents on the European Mammography Systems Market, then send an e-mail to Katja Feick, Corporate Communications, at katja.feick@frost.com, with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country. Upon receipt of the above information, a brief brochure will be sent to you by e-mail.

"The implementation of mobile screening units will generate more awareness in distant places," notes Frost & Sullivan Research Analyst Smruti Munshi. "In Europe, the trend is that of the mammography system going to the patient and not the patient coming for a mammogram, creating potential for market expansion."

There is significant geographic diversity in Europe, particularly in certain areas of the Netherlands and Scandinavia. Remote places face the problem of low installation. Accordingly, the provision of mobile vehicles with screening facilities will create greater awareness. The installation of mammography systems at these sites has been an issue and conducting screening programmes at these distant locations will be a very important driver for the mammography market.

"With an increase in mobile solutions, mobile screening will penetrate rural communities and improve their access to screening," adds Munshi. "Telemammography will enable the transmission of digital mammograms from one location to another for expert consultation."

As it takes a long time for women to obtain their results after a mobile mammogram test is done, most vendors ensure the mobility of their units. Additional tests, if required, can be conducted immediately with mobile digital mammography. Mobile units are also being used in hospitals in emergency rooms and operation theatres. The implementation of widespread screening should lead to increased mobile unit sales in the future.

However, the delayed implementation of screening programmes and certain government policies are retarding the growth of digital mammography systems. Budgetary constraints, paralleled by socio-economic factors, are mainly responsible for these delays. This severely affects the prospects of the mammography market as it postpones the installation of mammography systems.

In addition, in certain countries, digital mammography systems are still not encouraged as government policies demand film reading. For instance, countries such as France still believe in film screening for breast cancer. This has led to a huge drop in the growth of digital screening in the public healthcare sector. This has affected, in turn, the overall mammography systems market in Europe.

"Pricing will be critical to recovering the high level of investment that is required to develop and manufacture biosimilars," states Munshi. "In addition, marketing strategies will have to be very different from generic drugs."

As breast-screening programmes are very important to increase the installation of mammography systems market and promote market growth, major industry participants should lobby regional governments and the European Union Parliament to spread more awareness of this disease.

"Mammography vendors should lobby governments of individual countries, where screening is yet to be implemented," adds Munshi. "Germany has already experienced high sales because of many successful screening programmes that were implemented. For the overall market to expand, screening needs to be strongly encouraged across Europe."

Reimbursements are also very vital for market expansion. Lobbying should aim at promoting the reimbursement of the treatment rather than the diagnostic tool. Joint efforts with various advocacy groups such as women's rights groups and cancer therapy groups will be vital for market advancement.

European Mammography Systems Market is part of the Medical Imaging Growth Partnership Service programme, which also includes research in the following markets: European Medical Imaging Modalities used in the OR setting, European C-Arms Market, European Market for Emerging Applications of Ultrasound All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.

GIL 2009: Europe

Frost & Sullivan has expanded its flagship Global Congress on Corporate Growth - GIL Global - into several major cities around the world including London. For the first time ever in Europe, Frost & Sullivan will be hosting the Growth, Innovation and Leadership Congress 'GIL 2009: Europe' on 19-20 May, at the Sofitel St James in London. GIL Global is the industry's only event designed to support senior executives in their efforts to achieve sustainable, top-line growth. To register, obtain a programme agenda, explore sponsorship opportunities, or attend as a member of the media for GIL 2009: Europe, please contact Katja Feick, Corporate Communications Europe, at katja.feick@frost.com. One-on-One interviews with Frost & Sullivan senior growth consultants are also being scheduled. For more information you can also visit http://www.frost.com/gilglobal

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 35 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

                          European Mammography Systems Market
                                          M290

    Contact:
    Katja Feick
    Corporate Communications - Europe
    P: +49 (0) 69 7703343
    E: katja.feick@frost.com

   http://www.frost.com


'/>"/>
SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. South Africa not Gaining the Full Benefit of PPPs in the Healthcare Sector, Says Frost & Sullivan
2. Personalized Medicine Makes Significant Headway Following the Rapid Evolution of U.S. Molecular Diagnostics Market, Finds Frost & Sullivan
3. Frost & Sullivan: Rising Public Awareness Promoting Acceptance of Infection Surveillance Systems Across Europe
4. Higher Outlays and Improved Regulatory Enforcement Create Opportunities in the Kenyan Healthcare Industry, Reveals Frost & Sullivan
5. Frost & Sullivan: Global Government Reactions to Swine Flu Is Key
6. Frost & Sullivan Discusses Impact of Economic Meltdown on the European High Acuity Monitoring Systems Markets
7. Frost & Sullivan: The Pharmaceutical Customer Relationship Management Market - What are the Emerging Trends and Opportunities?
8. The Biometric Market - A Recession Proof Area of Growth and Opportunities, Says Frost & Sullivan
9. Innovation and Strategic Alliances Come to the Rescue of Participants in Mature Brazilian Market for Food Emulsifiers, Finds Frost & Sullivan
10. Generic Pharmaceuticals Offer Exciting Growth Opportunities in Tanzania, Reveals Frost & Sullivan
11. Frost & Sullivan and International Safety Equipment Association (ISEA) Present a Webinar on the Economy: Personal Protective Equipment Industry - Immune to Global Slowdown?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... CA (PRWEB) , ... April 28, 2017 , ... ... pleased to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians ... experience, since it streamlines the reporting process and provides a familiar interface that ...
(Date:4/28/2017)... , ... April 28, 2017 , ... Horizon Blue Cross ... the company’s credit rating of “A” and its outlook as “stable.” At the same ... reserves, which have fallen in recent years, dip below “capital adequacy” thresholds required for ...
(Date:4/28/2017)... York, NY (PRWEB) , ... April 28, 2017 ... ... Medical Laboratory to expanded distribution of the GlycoMark test throughout the Northeast U.S. ... recent hyperglycemia in patients with diabetes. The GlycoMark test provides a clinically proven ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... Replace tubes . These lamps offer an instant energy-saving solution for F32T8 fluorescent ... rewire fixtures or disconnect ballasts. These 50,000 hour rated lamps utilize the existing ...
(Date:4/28/2017)... ... April 28, 2017 , ... Datta Endoscopic ... has joined the revolutionary endoscopic practice under Dr. Datta. Patel is a Board ... Medicine. The patented, revolutionary eDiscSculpt Technique created and used by Datta Endoscopic is ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... the "Global Biosimilar Pipeline and Market Prospects: Addressing ... report to their offering. ... "Global Biosimilar Pipeline and Market ... by Design" provides an in-depth assessment of the current ...
(Date:4/20/2017)... , April 20, 2017  CVS Pharmacy, the ... unveiled a new store design to enhance the ... healthier food, health-focused products and expanded beauty selections ... help customers discover new offerings. Together with its ... evolution of the customer experience at CVS Pharmacy.  ...
(Date:4/20/2017)... 20, 2017 Research and Markets has ... Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, ... their offering. ... pharmacogenomics market was valued at US$ 7,167.6 Mn in 2015, ... expanding at a CAGR of 5.6% from 2016 to 2024. ...
Breaking Medicine Technology: